Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Drew Keyes
Health Policies In and Out of the CR
The House plans a “laddered” approach to a Continuing Resolution with a vote scheduled later today. This newsletter, authored by Drew Keyes, focuses on the health policy extenders in the legislation. It breaks down what policies are being extended, why there is pressure to address them, and what’s left out. Public Health Extenders Community Health Centers (CHCs): The bill extends three provisions related to CHCs that were originally enacted under the Affordable Care Act (ACA).
Short-Term Health Insurance Plans, Long-Term Benefits
This paper shows that from 2018 to 2023, ACA markets fared better in states allowing short-term health insurance, with higher enrollment and lower premiums, suggesting potential harm from proposed federal restrictions on these policies. What This Paper Covers In 2018,the Trump administration liberalized federal requirements around short-term limited-duration health insurance (STLDI).
New report reveals how CDC can be ready for the next pandemic Original
NEWYou can now listen to Fox News articles! The Centers for Disease Control and Prevention has a new director, Dr. Mandy Cohen. Her predecessor, Dr. Rochelle Walensky, acknowledged CDC was "responsible for some pretty dramatic, pretty public mistakes—from testing, to data, to communications," during the COVID-19 pandemic. Unfortunately, nothing indicates that Dr. Cohen has diagnosed the cause, much less prescribed a cure, for what ails the agency.
New report reveals how CDC can be ready for the next pandemic
The Centers for Disease Control and Prevention has a new director, Dr. Mandy Cohen. Her predecessor, Dr. Rochelle Walensky, acknowledged CDC was “responsible for some pretty dramatic, pretty public mistakes—from testing, to data, to communications,” during the COVID-19 pandemic. Unfortunately, nothing indicates that Dr. Cohen has diagnosed the cause, much less prescribed a cure, for what ails the agency.
Unauthorized and Unprepared: Refocusing the CDC after COVID-19
The Centers for Disease Control and Prevention, the nation’s preeminent public health agency, has acknowledged that it failed badly during the COVID-19 pandemic. This paper examines why and suggests how the agency can be reformed and refocused. The basic problem was CDC mission creep, abetted by the lack of congressional authorization for the agency. Because the CDC has never been fully authorized by Congress, it lacks goals, circumscribed powers, and effective oversight.
Congress should resist the impulse to use PAHPA reauthorization to comprehensively reform the CDC
The Pandemics and All-Hazards Preparedness Act expires on September 30. The law, which was originally enacted in 2006, organizes federal health preparedness and response efforts, focusing on public health security and bioterrorism preparedness. The reauthorization comes under heightened scrutiny following the COVID-19 pandemic. This policy brief details the law’s history, its efficacy during the COVID-19 pandemic, and considerations for Congress as it reauthorizes the law. Joel M.
Unauthorized and Unprepared: Refocusing the CDC after COVID-19
The Centers for Disease Control and Prevention, the nation’s preeminent public health agency, has acknowledged that it failed badly during the COVID-19 pandemic. This paper examines why and suggests how the agency can be reformed and refocused. The basic problem was CDC mission creep, abetted by the lack of congressional authorization for the agency. Because the CDC has never been fully authorized by Congress, it lacks goals, circumscribed powers, and effective oversight.
Congress Should Not Do the Bidding of a Dying Trade Association
The pharmaceutical industry has lost its lobbying edge, and Congress should ignore its latest, panicked rebrand, an all-out offensive against Pharmacy Benefit Managers (PBMs), the entities that manage health insurance prescription benefits. But before policymakers give credence to pharma’s narrative, they may want to look closely at the flailing trade association.
Paragon’s Drew Keyes and Joel Zinberg Respond to Request for Information on congressional efforts to reform and improve the Centers for Disease Control and Prevention (CDC) - Paragon Institute
On May 3, 2023, Paragon’s Joel Zinberg and Drew Keyes published a response to a request for information (RFI) on congressional efforts to reform and improve the Centers for Disease Control and Prevention (CDC). The RFI came from Representative Mariannette Miller-Meeks. About the Authors Dr. Joel M. Zinberg is the Director the Public Health and American Well-Being Initiative at Paragon Health Institute, and a senior fellow with the Competitive Enterprise Institute.
End the Covid Emergency Now
Congress should ignore the Biden administration's false alarms and end the Covid emergency now.
White House Renews Emergency Declaration for the 12th Time
On January 12, 2023, Paragon’s Brian Blase, PhD, and Drew Keyes were quoted in Health Care News by the Heartland Institute. From the article titled “White House Renews Emergency Declaration for the 12th Time”: The Biden Administration’s handling of COVID-19 will dominate much of the debate in the new Congress as Republicans lead the House with a slight majority.
In Omnibus Bill, Health Lobbyists Win, We Lose | National Review
The omnibus bill expands government, subsidizes big business, and ignores the interests of taxpayers while circumventing regular order in Congress.
In Omnibus Bill, Health Lobbyists Win, We Lose
The omnibus is Washington at its worst. It’s a huge end-of-year $1.7 trillion spending bill loaded with significantly expanded government authorities and programs and little opportunity for most members of Congress, much less the American public, to review it. This bill also shows that neither Congress nor the White House is serious about huge annual budget deficits and 40-year-high inflation, choosing instead to double down on reckless fiscal policy.
Congress is giving a misguided Christmas gift to CDC
It’s the Christmas season in Congress. Just like a procrastinating college student cramming for finals, members have one foot out the door for Christmas break and the other pointed toward the work they should have already done. This lame-duck session is proving to be no different, with a variety of issues that Congress must address before heading home for eggnog. Every lame duck brings its own form of Congress at its worst.
Health Care Policy in the Lame Duck
As the 117th Congress ends, much focus is already on the make-up and agenda for the 118th Congress. However, there are several key health policy changes that will likely be considered in the current lame-duck session as part of a larger appropriations measure. Current appropriations are set to expire on December 16th. This policy brief will analyze which policies will likely be considered and how policymakers should or should not address these issues.
Three Cheers For Over-The-Counter Hearing Aids
This past week, the Food and Drug Administration finally took the commonsense step to allow patients to buy hearing aids over the counter (OTC), or without a prescription. This action should help millions of Americans with hearing loss by reducing the cost, including wait times, of getting the assistance that they need. It should also spur competition among hearing aid manufacturers and distributors to better meet patient needs, patients like Brian Barbera.
Brian Blase in The Wall Street Journal for “An Alternative to Expanded ObamaCare Subsidies"
Yesterday, the Wall Street Journal published my op-ed “An Alternative to Expanded ObamaCare Subsidies,” offering a sensible alternative to the unwise Affordable Care Act (ACA) subsidy expansion contained in the Democratic reconciliation bill. The expanded subsidies, enacted in the American Rescue Plan (ARP) Act, expire after 2022. This presents Democrats with a political problem since enrollees would face premium increases right before the midterm elections.
POLICY BRIEF: Reconciliation Bill - Misguided Drug Price Controls and Unwise Health Insurer Subsidies
As Americans face rising inflation and recession risk, Congressional Democrats have proposed a misguided budget reconciliation bill focusing on health care. The legislation would set price controls on prescription drugs and limit price increases to the rate of inflation. It would extend elevated Affordable Care Act (ACA) subsidies—enacted under the American Rescue Plan and set to expire after 2022—for at least two more years.
POLICY BRIEF: The INSULIN Act - Higher insulin prices and less innovation
Congressional Democrats are mounting renewed efforts to impose drug price controls. One effort is contained in a new reconciliation proposal. Another, separate measure specifically addresses insulin prices in the INSULIN Act introduced by Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Drew
Contact Drew, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack